X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE CADILA HEALTHCARE SUVEN LIFE/
CADILA HEALTHCARE
 
P/E (TTM) x 17.2 16.6 103.7% View Chart
P/BV x 3.6 3.9 90.3% View Chart
Dividend Yield % 0.6 1.0 61.7%  

Financials

 SUVEN LIFE   CADILA HEALTHCARE
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
CADILA HEALTHCARE
Mar-18
SUVEN LIFE/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs251558 44.9%   
Low Rs155362 42.9%   
Sales per share (Unadj.) Rs49.1116.3 42.2%  
Earnings per share (Unadj.) Rs9.717.9 54.4%  
Cash flow per share (Unadj.) Rs11.423.1 49.2%  
Dividends per share (Unadj.) Rs1.503.50 42.9%  
Dividend yield (eoy) %0.70.8 97.1%  
Book value per share (Unadj.) Rs60.385.4 70.6%  
Shares outstanding (eoy) m127.281,023.74 12.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.14.0 104.5%   
Avg P/E ratio x20.925.7 81.1%  
P/CF ratio (eoy) x17.819.9 89.6%  
Price / Book Value ratio x3.45.4 62.5%  
Dividend payout %15.419.6 78.8%   
Avg Mkt Cap Rs m25,825470,664 5.5%   
No. of employees `0001.111.8 9.1%   
Total wages/salary Rs m61318,545 3.3%   
Avg. sales/employee Rs Th5,832.610,072.7 57.9%   
Avg. wages/employee Rs Th571.51,569.1 36.4%   
Avg. net profit/employee Rs Th1,153.81,547.7 74.5%   
INCOME DATA
Net Sales Rs m6,253119,049 5.3%  
Other income Rs m2331,132 20.6%   
Total revenues Rs m6,485120,181 5.4%   
Gross profit Rs m1,98228,475 7.0%  
Depreciation Rs m2135,388 4.0%   
Interest Rs m46911 5.1%   
Profit before tax Rs m1,95523,308 8.4%   
Minority Interest Rs m0628 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7185,644 12.7%   
Profit after tax Rs m1,23718,292 6.8%  
Gross profit margin %31.723.9 132.5%  
Effective tax rate %36.724.2 151.7%   
Net profit margin %19.815.4 128.7%  
BALANCE SHEET DATA
Current assets Rs m5,62282,005 6.9%   
Current liabilities Rs m1,16860,720 1.9%   
Net working cap to sales %71.217.9 398.5%  
Current ratio x4.81.4 356.5%  
Inventory Days Days8173 111.3%  
Debtors Days Days3698 36.5%  
Net fixed assets Rs m3,32583,703 4.0%   
Share capital Rs m1271,024 12.4%   
"Free" reserves Rs m7,54786,421 8.7%   
Net worth Rs m7,67487,445 8.8%   
Long term debt Rs m1425,551 0.1%   
Total assets Rs m9,135180,653 5.1%  
Interest coverage x43.226.6 162.6%   
Debt to equity ratio x00.3 0.6%  
Sales to assets ratio x0.70.7 103.9%   
Return on assets %14.010.6 132.1%  
Return on equity %16.120.9 77.0%  
Return on capital %26.022.0 118.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,06642,683 11.9%   
Fx outflow Rs m2,00111,242 17.8%   
Net fx Rs m3,06531,441 9.7%   
CASH FLOW
From Operations Rs m6999,193 7.6%  
From Investments Rs m-6-9,737 0.1%  
From Financial Activity Rs m-577515 -112.0%  
Net Cashflow Rs m116-29 -401.0%  

Share Holding

Indian Promoters % 63.4 74.8 84.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 8.3 -  
FIIs % 0.0 5.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 11.0 331.8%  
Shareholders   37,287 44,069 84.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   DISHMAN PHARMA  ELDER PHARMA  VENUS REMEDIES  PANACEA BIOTECH  GLENMARK PHARMA  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Metal & Realty Stocks Drag(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.1% while the Hang Seng is down 0.5%.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Up 274.4% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (up 274.4% YoY). Sales on the other hand came in at Rs 29 bn (up 29.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 16, 2018 11:59 AM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - DIVIS LABORATORIES COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS